Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations.
Expert Opin Investig Drugs. 2019 Aug;28(8):675-686. doi: 10.1080/13543784.2019.1646726. Epub 2019 Jul 29.
Expert Opin Investig Drugs. 2019.
PMID: 31327293
Review.
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma.
Mahadevan D, Northfelt DW, Chalasani P, Rensvold D, Kurtin S, Von Hoff DD, Borad MJ, Tibes R.
Mahadevan D, et al. Among authors: rensvold d.
Int J Clin Oncol. 2013 Oct;18(5):934-41. doi: 10.1007/s10147-012-0475-8. Epub 2012 Oct 11.
Int J Clin Oncol. 2013.
PMID: 23053399
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I trial of AEG35156 an antisense oligonucleotide to XIAP plus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma.
Mahadevan D, Chalasani P, Rensvold D, Kurtin S, Pretzinger C, Jolivet J, Ramanathan RK, Von Hoff DD, Weiss GJ.
Mahadevan D, et al. Among authors: rensvold d.
Am J Clin Oncol. 2013 Jun;36(3):239-43. doi: 10.1097/COC.0b013e3182467a13.
Am J Clin Oncol. 2013.
PMID: 22441342
Clinical Trial.
Item in Clipboard
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors.
Mahadevan D, Plummer R, Squires MS, Rensvold D, Kurtin S, Pretzinger C, Dragovich T, Adams J, Lock V, Smith DM, Von Hoff D, Calvert H.
Mahadevan D, et al. Among authors: rensvold d.
Ann Oncol. 2011 Sep;22(9):2137-2143. doi: 10.1093/annonc/mdq734. Epub 2011 Feb 16.
Ann Oncol. 2011.
PMID: 21325451
Free article.
Clinical Trial.
Item in Clipboard
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.
Mahadevan D, Chiorean EG, Harris WB, Von Hoff DD, Stejskal-Barnett A, Qi W, Anthony SP, Younger AE, Rensvold DM, Cordova F, Shelton CF, Becker MD, Garlich JR, Durden DL, Ramanathan RK.
Mahadevan D, et al. Among authors: rensvold dm.
Eur J Cancer. 2012 Dec;48(18):3319-27. doi: 10.1016/j.ejca.2012.06.027. Epub 2012 Aug 23.
Eur J Cancer. 2012.
PMID: 22921184
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite